Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « November » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   - « November » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fang, Wujie
NCT05269173: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease	Completed	2	240	RoW	Flos gossypii flavonoids tablet	Capital Medical University, Xinjiang Uygur Pharmaceutical Co., Ltd.	Alzheimer Disease	08/24	11/24
Chen, Jingfeng
NCT07007286: Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer	Not yet recruiting	N/A	1500	RoW	ETV,TDF,TAF,TMF combination with PEG IFNα-2b, ETV,TDF,TAF or TMF	Peking University First Hospital	HBV, HCC	01/32	12/32

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fang, Wujie
NCT05269173: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease	Completed	2	240	RoW	Flos gossypii flavonoids tablet	Capital Medical University, Xinjiang Uygur Pharmaceutical Co., Ltd.	Alzheimer Disease	08/24	11/24
Chen, Jingfeng
NCT07007286: Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancer	Not yet recruiting	N/A	1500	RoW	ETV,TDF,TAF,TMF combination with PEG IFNα-2b, ETV,TDF,TAF or TMF	Peking University First Hospital	HBV, HCC	01/32	12/32